Clinical Trials in Taiyuan, Shangxi
2 recruiting
Showing 1–2 of 2 trials
Recruiting
Phase 2
DZD8586 in Patients With Relapsed or Refractory CLL/SLL (TAI-SHAN8)
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Dizal Pharmaceuticals155 enrolled17 locationsNCT06539182
Recruiting
Not Applicable
CD30 CAR-T in the Treatment of CD30 Positive Relapsed/Refractory Lymphoma
Lymphoma, B-Cell
Shanxi Bethune Hospital15 enrolled1 locationNCT06850285